Cargando…

Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies

Detalles Bibliográficos
Autores principales:	Lafont, Bernard A.P., Bennink, Jack R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2020
Materias:	Opinions and Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185310/ https://www.ncbi.nlm.nih.gov/pubmed/32286176 http://dx.doi.org/10.1089/vim.2019.0167

Ejemplares similares

Synergistic Effects of Multiple Factors Involved in COVID-19-dependent Muscle Loss
por: Cantu, Nicholas, et al.
Publicado: (2022)

Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules
por: Prasad, Ashish, et al.
Publicado: (2020)

The role of human immunity and social behavior in shaping influenza evolution
por: Kucharski, Adam J., et al.
Publicado: (2017)

Vaccination of poultry against highly pathogenic avian influenza – part 1. Available vaccines and vaccination strategies
por: Nielsen, Søren Saxmose, et al.
Publicado: (2023)

Age-specificity and the evolution of senescence: a discussion
por: Wensink, Maarten
Publicado: (2012)

Can the disease course in Parkinson’s disease be slowed?
por: Korczyn, Amos D., et al.
Publicado: (2015)

Can Virus-like Particles Be Used as Synergistic Agent in Pest Management?
por: Deshayes, Caroline, et al.
Publicado: (2022)

DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
por: Oberemok, Volodymyr V., et al.
Publicado: (2023)

Developmental heterochrony and the evolution of autistic perception, cognition and behavior
por: Crespi, Bernard
Publicado: (2013)

Delay or Giving Up of Influenza Vaccination Induced by Unscientific Journalism Makes Influenza Outbreak and Its Subsequent Cardiovascular Death Surges Especially in Elderly
por: Bae, Jang-Whan
Publicado: (2020)

The COVID-19 vaccination campaign in Bhutan: strategy and enablers
por: Tsheten, Tsheten, et al.
Publicado: (2022)

Honey Bee Antiviral Immune Barriers as Affected by Multiple Stress Factors: A Novel Paradigm to Interpret Colony Health Decline and Collapse
por: Nazzi, Francesco, et al.
Publicado: (2018)

Combining Antivirals and Immunomodulators to Fight COVID-19
por: Feuillet, Vincent, et al.
Publicado: (2021)

Advances in Influenza Virus Research: A Personal Perspective
por: Subbarao, Kanta
Publicado: (2018)

Thapsigargin: key to new host-directed coronavirus antivirals?
por: Shaban, Mohammed Samer, et al.
Publicado: (2022)

Vaccination strategies for measles control and elimination: time to strengthen local initiatives
por: Cutts, F. T., et al.
Publicado: (2021)

Viruses take center stage in cellular evolution
por: Claverie, Jean-Michel
Publicado: (2006)

Type 1 Interferons and Antiviral CD8 T-Cell Responses
por: Welsh, Raymond M., et al.
Publicado: (2012)

Egyptian H5N1 Influenza Viruses—Cause for Concern?
por: Neumann, Gabriele, et al.
Publicado: (2012)

Immunoglobulin Superfamily Virus Receptors and the Evolution of Adaptive Immunity
por: Dermody, Terence S., et al.
Publicado: (2009)

Epidemiologic Evaluation and Risk Communication Regarding the Recent Reports of Sudden Death after Influenza Vaccination in the COVID-19 Pandemic
por: Jung, Jaehun
Publicado: (2020)

The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics
por: Neumann, Gabriele, et al.
Publicado: (2023)

Putting “Heavy” into Heavy Slow Resistance
por: Morrison, Scot, et al.
Publicado: (2022)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
por: Tonk, Miray, et al.
Publicado: (2021)

A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals
por: Olivet, Julien, et al.
Publicado: (2022)

Antiviral Strategies for Emerging Influenza Viruses in Remote Communities
por: Laskowski, Marek, et al.
Publicado: (2014)

H5N1 Viruses and Vaccines
por: Subbarao, Kanta, et al.
Publicado: (2007)

Is evolution Darwinian or/and Lamarckian?
por: Koonin, Eugene V, et al.
Publicado: (2009)

Antiviral Strategies for Pandemic and Seasonal Influenza
por: Hedlund, Maria, et al.
Publicado: (2010)

Multiple Vaccines and Strategies for Pandemic Preparedness of Avian Influenza Virus
por: Xu, Hai, et al.
Publicado: (2023)

Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19
por: Tripp, Ralph A., et al.
Publicado: (2023)

Mayr, mathematics and the study of evolution
por: Crow, James F
Publicado: (2009)

Evolution of negative immune regulators
por: Frank, Steven A., et al.
Publicado: (2019)

Is antimicrobial resistance evolution accelerating?
por: Witzany, Christopher, et al.
Publicado: (2020)

Evolution of Tumor Metabolism might Reflect Carcinogenesis as a Reverse Evolution process (Dismantling of Multicellularity)
por: Alfarouk, Khalid O., et al.
Publicado: (2011)

COP26 and Health: Some Progress, But Too Slow and Not Enough
por: Laybourn-Langton, Laurie, et al.
Publicado: (2022)

Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir
por: Bakacs, Tibor, et al.
Publicado: (2023)

Regulatory T Cells Suppress Antiviral Immune Responses and Increase Viral Loads during Acute Infection with a Lymphotropic Retrovirus
por: Zelinskyy, Gennadiy, et al.
Publicado: (2009)

Enzymatic Properties of the Neuraminidase of Seasonal H1N1 Influenza Viruses Provide Insights for the Emergence of Natural Resistance to Oseltamivir
por: Rameix-Welti, Marie-Anne, et al.
Publicado: (2008)

On the evolution of the standard amino-acid alphabet
por: Lu, Yi, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_lnsfkdvs9klf8qs5r39tqrpbkj